Logos Global Management LP Keros Therapeutics, Inc. Transaction History

Logos Global Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$36.95 - $62.89 $554,250 - $943,350	-15,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.27 - $43.71 $439,050 - $655,650	15,000 New	15,000 $593,000
Q1 2021 May 17, 2021	SELL	$54.0 - $75.28 $24.3 Million - $33.9 Million	-450,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$36.0 - $82.74 $41.4 Million - $95.2 Million	-1,150,000 Reduced 71.88%	450,000 $31.7 Million
Q3 2020 Nov 16, 2020	BUY	$27.04 - $62.21 $32.4 Million - $74.7 Million	1,200,000 Added 300.0%	1,600,000 $61.7 Million
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $8.03 Million - $16.2 Million	400,000 New	400,000 $15 Million

174

30.3M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.46B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.